Cannabidiol Enforcement Policy; Draft Guidance for Industry
FDA Withdraws Draft Guidance on CBD Enforcement Policy
After the Biden administration released a memo on Jan. 20 to all federal agencies informing them of a “regulatory freeze pending review,” the U.S. Food and Drug Administration (FDA) withdrew its “Cannabidiol Enforcement Policy; Draft Guidance for Industry.” Before it was withdrawn, the guidance was at the Office of Management and Budget (OMB) awaiting review. In ...
FDA Submits CBD Enforcement Guidance to White House For Review
U.S. Food and Drug Administration (FDA) has submitted draft CBD (cannabidiol) enforcement guidance to the White House Office of Management and Budget (OMB) for review, according to Marijuana Moment. The contents or even basic scope of the document titled, “Cannabidiol Enforcement Policy; Draft Guidance for Industry,” are not yet publicly known. The agency was mandated ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!